Article
Vimentin is required for tumor progression and metastasis in a mouse model of non–small cell lung cancer
9 May 2023
Abstract excerpt
Abstract Vimentin is highly expressed in metastatic cancers, and its expression correlates with poor patient prognoses. However, no causal in vivo studies linking vimentin and non–small cell lung cancer (NSCLC) progression existed until now. We use three complementary in vivo models to show that vimentin is required for the progression of NSCLC. First, we crossed LSL-Kras G12D ; Tp53 fl/fl mice ( KPV +/+ ) with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
